BI Asset Management Fondsmaeglerselskab A S Sells 5,055 Shares of Stryker Co. (NYSE:SYK)

20 Apr 2025, 10:14 by Teresa Graham · The Cerbat Gem

BI Asset Management Fondsmaeglerselskab A S cut its position in Stryker Co. (NYSE:SYK – Free Report) by 22.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 17,769 shares of the medical technology company’s stock after selling 5,055 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Stryker were worth $6,398,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of SYK. Dimensional Fund Advisors LP raised its stake in shares of Stryker by 2.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 828,303 shares of the medical technology company’s stock worth $298,246,000 after acquiring an additional 18,897 shares in the last quarter. Forum Financial Management LP grew its holdings in Stryker by 31.7% in the fourth quarter. Forum Financial Management LP now owns 2,455 shares of the medical technology company’s stock worth $884,000 after purchasing an additional 591 shares during the last quarter. Commerce Bank increased its position in shares of Stryker by 1.6% during the fourth quarter. Commerce Bank now owns 183,427 shares of the medical technology company’s stock worth $66,043,000 after purchasing an additional 2,904 shares in the last quarter. CANADA LIFE ASSURANCE Co lifted its holdings in shares of Stryker by 4.3% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 349,807 shares of the medical technology company’s stock valued at $125,901,000 after purchasing an additional 14,397 shares during the last quarter. Finally, Tobias Financial Advisors Inc. acquired a new stake in shares of Stryker in the 4th quarter worth $241,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Stryker

In related news, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the transaction, the director now directly owns 3,642,075 shares of the company’s stock, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Allan C. Golston sold 2,458 shares of Stryker stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total transaction of $941,586.06. Following the sale, the director now directly owns 14,895 shares in the company, valued at approximately $5,705,827.65. This trade represents a 14.16 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 5.90% of the company’s stock.

Stryker Stock Performance

Shares of NYSE SYK opened at $346.46 on Friday. Stryker Co. has a 1 year low of $314.93 and a 1 year high of $406.19. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95. The company’s fifty day moving average price is $370.95 and its 200 day moving average price is $373.16. The company has a market capitalization of $132.24 billion, a PE ratio of 44.65, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK – Get Free Report) last announced its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, beating the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same period last year, the firm posted $3.46 earnings per share. On average, research analysts predict that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 0.97%. The ex-dividend date is Monday, March 31st. Stryker’s payout ratio is 43.30%.

Wall Street Analysts Forecast Growth

SYK has been the topic of several recent analyst reports. Needham & Company LLC reaffirmed a “buy” rating and set a $442.00 target price on shares of Stryker in a research report on Friday, March 21st. Canaccord Genuity Group increased their price objective on shares of Stryker from $420.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. Stifel Nicolaus boosted their target price on shares of Stryker from $400.00 to $440.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Citigroup reaffirmed a “buy” rating and issued a $450.00 price target on shares of Stryker in a report on Wednesday, February 26th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Stryker from $420.00 to $445.00 and gave the company an “overweight” rating in a report on Wednesday, January 29th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and an average target price of $423.53.

Read Our Latest Stock Analysis on Stryker

About Stryker

(Free Report)